E-LIB Suche - Ergebnisse für: Zuckerman, E.

1

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ±..:

Brown, A. ; Hézode, C. ; Zuckerman, E....
Journal of Viral Hepatitis. 25 (2018) 5 - p. 457-464 , 2018

Link: https://doi.org/10.1111/..

2

Increased killer B cells in chronic HCV infection may lead ..:

Eiza, N ; Zuckerman, E ; Carlebach, M...
Clinical and Experimental Immunology. 193 (2018) 2 - p. 183-193 , 2018

Link: https://doi.org/10.1111/..

3

Real‐world effectiveness of ombitasvir/paritaprevir/ritonav..:

Wedemeyer, H. ; Craxí, A. ; Zuckerman, E....
Journal of Viral Hepatitis. 24 (2017) 11 - p. 936-943 , 2017

Link: https://doi.org/10.1111/..

4

Safety of glecaprevir/pibrentasvir in adults with chronic g..:

Dufour, J.-F. ; Zuckerman, E. ; Zadeikis, N....
Journal of Hepatology. 66 (2017) 1 - p. S515 , 2017

Link: https://doi.org/10.1016/..

5

The point of care 13C-Methacetin Breath Test predicts risk ..:

Shiffman, M.L. ; Siddiqui, M.S. ; Khoury, T....
Journal of Hepatology. 66 (2017) 1 - p. S668-S669 , 2017

Link: https://doi.org/10.1016/..

6

Increased killer B cells: are they associated with increase..:

Zuckerman, E. ; Eiza, N. ; Carlebach, M....
Journal of Hepatology. 66 (2017) 1 - p. S330 , 2017

Link: https://doi.org/10.1016/..

7

Prevalence and Clinical Importance of Hepatitis C Virus Gen..:

Susser, S. ; Dietz, J. ; Barak, M....
Journal of Hepatology. 64 (2016) 2 - p. S136 , 2016

Link: https://doi.org/10.1016/..

8

High Efficacy of an 8-Week 3-Drug Regimen of Grazoprevir/MK..:

Gane, E.J. ; Pianko, S. ; Roberts, S.K....
Journal of Hepatology. 64 (2016) 2 - p. S759 , 2016

Link: https://doi.org/10.1016/..

9

Efficacy and safety of grazoprevir + ribavirin for 12 or 24..:

Gane, E. ; Ben Ari, Z. ; Mollison, L....
Journal of Viral Hepatitis. 23 (2016) 10 - p. 789-797 , 2016

Link: https://doi.org/10.1111/..

10

The Real-World Israeli Experience of Treating Chronic Hepat..:

Zuckerman, E. ; Ashkenasi, E. ; Kovalev, Y....
Journal of Hepatology. 64 (2016) 2 - p. S137 , 2016

Link: https://doi.org/10.1016/..

11

Historical epidemiology of hepatitis C virus (HCV) in selec..:

Saraswat, V. ; Norris, S. ; de Knegt, R. J....
Journal of Viral Hepatitis. 22 (2015) - p. 6-25 , 2015

Link: https://doi.org/10.1111/..

12

P0771 : C-SCAPE: Efficacy and safety of 12 weeks of grazopr..:

Brown, A. ; Hezode, C. ; Zuckerman, E....
Journal of Hepatology. 62 (2015) - p. S619 , 2015

Link: https://doi.org/10.1016/..

13

LP02 : C-surfer: grazoprevir plus elbasvir in treatment-nai..:

Roth, D. ; Nelson, D. ; Bruchfeld, A....
Journal of Hepatology. 62 (2015) - p. S263-S264 , 2015

Link: https://doi.org/10.1016/..

14

O001 : C-salvage: grazoprevir (GZR; MK-5172), elbasvir (EBR..:

Forns, X. ; Gordon, S. ; Zuckerman, E....
Journal of Hepatology. 62 (2015) - p. S190 , 2015

Link: https://doi.org/10.1016/..

15

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/..:

Hezode, C. ; Serfaty, L. ; Vierling, J.M....
Journal of Hepatology. 60 (2014) 1 - p. S5 , 2014

Link: https://doi.org/10.1016/..